Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer ...
TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 ...
Worldcrunch on MSN13h
Germany's Trillion: How A Record Investment Plan Could Reshape The NationGermany has finally decided to start spending. Is this going to save its stagnating economy? The new fiscal package is the ...
Hippocratic AI initially promoted a rate of $9 an hour for its AI assistants, compared with about $40 an hour for a ...
But after further examination, Hart determined that he was treating a dialysis patient, or someone with kidney failure. Such patients have to be carefully managed to avoid overloading their ...
But after further examination, Hart determined that he was treating a dialysis patient, or someone with kidney failure. Such patients have to be carefully managed to avoid overloading their ...
Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led ...
The recent approvals and robust pipeline activity are expected to fuel the market of molecular glues in the 7MM during the forecast period 2025-2034 due to factors like improved diagnosis, treatment ...
BBC Sport are set to oversee a significant change to their current approach with redundancies expected as they strive to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback